University of Kansas Medical Center
Westwood, Kansas 66205
5 studies enrolling now · 41 studies all time
What they study most
AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia (ALL), Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Acute-graft-versus-host Disease, Adult Acute Lymphoid Leukemia, Adult Acute Myeloid Leukemia, B-cell Lymphoma
Studies at this site
- A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
- A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation — Recruiting now
- Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia — Recruiting now
- Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
- Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer — Stopped early
- Study of Oral LOXO-338 in Patients With Advanced Blood Cancers — Completed
- A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies — Running, not enrolling
- A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
- Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC — Stopped early
- Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma — Completed
- A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV — Running, not enrolling
- Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer — Completed
- Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) — Completed
- SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
- Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy — Completed
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
- Alvocidib Biomarker-driven Phase 2 AML Study — Stopped early
- Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy — Stopped early
- ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
- An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) — Completed
- TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early
- Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
- Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
- An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) — Completed
- A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
- A Post-Marketing Observational Study of VYXEOS™ — Completed
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts — Completed
- A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer — Completed
- VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer — Completed
- A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants — Completed
- A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes — Completed
- Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) — Completed
- Vitamin D3 for Aromatase Inhibitor Induced Arthralgias — Completed
- Stem Cell Related Donor Safety Study — Completed
- Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML — Completed
- Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia — Completed
- A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
- An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer — Completed
- PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients — Completed
- A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse — Completed